超微血流成像技术在评估妊娠期高血压疾病胎盘灌注中的应用价值分析

Value of superb micro-vascular imaging in assessment of placenta of hypertensive disorder complicating pregnancy

  • 摘要:
      背景  妊娠期高血压疾病的不良结局严重危害母儿健康,目前临床指标早期预测能力有限。超微血流成像(superb micro-vascular imaging,SMI)技术提供胎盘灌注定量指标,为早期预测不良结局提供可能。
      目的  探索SMI定量评价妊娠期高血压疾病胎盘血管灌注的价值。
      方法  选择2019年10月- 2021年10月在我中心常规超声检查并应用SMI评估胎盘灌注的孕晚期(28 ~ 32周)孕妇。应用超微血流成像技术观察各组胎盘的血流灌注情况、定量指标血管化指数(vascularization index,VI)、多普勒超声检测脐动脉收缩期最大血流速度与舒张期期末血流速度比值(S/D)以及孕妇的血压值,并随访妊娠结局至产后1个月,低体质量新生儿、胎儿窘迫、新生儿窒息和围生儿死亡作为不良妊娠结局。分析以上指标对不良结局的敏感度和特异性,绘制ROC曲线,计算曲线下面积(AUC)和各截断值。
      结果  纳入正常组90例,妊娠期高血压疾病(hypertensive disorder of pregnancy,HDP)组52例妊娠期高血压(gestational hypertension,GHT) 35例,子痫前期(preeclampsia,PE) 12例,子痫(eclampsia) 5例。HDP组低体质量新生儿7例、胎儿窘迫10例、新生儿窒息6例,发生率高于正常组(分别为3例、4例、1例,P均<0.05)。SMI胎盘灌注图显示,HDP组孕妇胎盘内绒毛血管管径粗细不均、走行不规则,仅显示靠近表面的初级、次级绒毛血管,未显示子宫螺旋动脉及其分支。与正常组 (16.2) 比较,GHT组、PE组、子痫组的胎盘中位VI值依次为10.2、7.0、4.1,组间比较差异均有统计学意义(P均<0.05)。正常组与GHT组、PE组和子痫组的S/D比值差异无统计学意义(P>0.05)。ROC分析显示收缩压、舒张压、S/D、VI这4项指标及联合应用对不良妊娠结局的预测效能:ROC-AUC(95% CI)分别为0.740(0.569 ~ 0.911)、0.719(0.452 ~ 0.972)、0.698(0.434 ~ 0.959)、0.769(0.545 ~ 0.969)、0.863(0.782 ~ 0.951),其中联合应用诊断效能较高。
      结论  孕晚期运用SMI技术可以定量评估妊娠期高血压疾病的严重程度,VI对预测不良妊娠结局有较高的临床价值。

     

    Abstract:
      Background  The adverse outcome of hypertensive disorder complicating pregnancy seriously endangers the health of mother and child, and the ability of early prediction of clinical indicators is limited at present. Superb micro-vascular imaging (SMI) provides quantitative indicators of placental perfusion, which may provide early prediction of adverse outcomes.
      Objective  To explore the value of quantitative evaluation of SMI in placental vascular perfusion of hypertensive disorder complicating pregnancy.
      Methods  From October 2019 to October 2021, pregnant women in the third trimester (28 w - 32 w) with placenta perfusion evaluated by routine ultrasound examination and SMI in our center were included in this study. The blood flow perfusion of placenta in each group was observed by SMI, and the quantitative indexes of vascularization index (VI), the ratio of the peak systolic blood flow velocity of umbilical artery to the end diastolic blood flow velocity (S/D) and the blood pressure of pregnant women were recorded, and the pregnancy outcomes were followed up until one month after delivery. Low birth weight, fetal distress, neonatal asphyxia and perinatal death were the adverse pregnancy outcomes. The sensitivity and specificity of the above indicators were analyzed, ROC curve was drawn, and the area under the curve (AUC) and each cut-off values were calculated.
      Results  There were 90 cases in the normal control group, and 52 cases in the hypertensive disorder of pregnancy (HDP) group, including 35 cases with gestational hypertension (GHT), 12 cases with preeclampsia (PE) and 5 cases with eclampsia. In the HDP group, there were 7 cases of low birth weight, 10 cases of fetal distress and 6 cases of neonatal asphyxia, and the incidences were higher than those in normal group(3cases, 4cases, 1case, respectively) (all P < 0.05). The SMI placental perfusion map of pregnant women in the HDP group showed that the diameter of villous blood vessels in placenta was uneven and irregular, showing only the primary and secondary villous blood vessels near the surface, without the uterine spiral artery and its branches. Compared with the normal group(VI, 16.2), the placental median VI values of the GHT group, the PE group and the eclampsia group were 10.2, 7.0 and 4.1, respectively (P < 0.05). There was no significant difference in S/D ratio between the normal group and the GHT group, the PE group and the eclampsia group (P > 0.05). ROC analysis shows that SBP, DBP, S/D, VI and their combined application could predict the adverse pregnancy outcome, with ROC-AUC (95% CI) of 0.740 (0.569-0.911), 0.719 (0.452-0.972), 0.698 (0.434-0.959), 0.769 (0.545-0.969), 0.863(0.782-0.951). Among them, the diagnostic efficiency of combined application was higher.
      Conclusion  SMI technology can be used in late pregnancy to assess the severity of hypertensive disorder complicating pregnancy early and quantitatively, and VI has a high clinical value in predicting adverse pregnancy outcomes.

     

/

返回文章
返回